Patent
 (2018)

njectable pharmaceutical composition of a single dose and prolonged release comprising polymeric nanoparticles composed of poly-lactic acid bound to poly-ethylene glycol (mpeg-plla), loaded with probenicid as a drug that inhibits the panexin-1 channel, useful for treating or preventing pain chronic, in animals or humans (divisional 3772-15)